The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the ...
In this article, we discuss the top 10 healthcare stock picks of Timothy P. Lynch's Stonepine Capital. If you want to skip our detailed analysis of these stocks, go directly to Timothy P.
In this article, we discuss the top 5 healthcare stock picks of Timothy P. Lynch's Stonepine Capital. If you want our detailed analysis of these stocks, go directly to Timothy P.
Were Hedge Funds Right About ContraFect Corp (CFRX)?
In this article we will analyze whether ContraFect Corp (NASDAQ:CFRX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into their best ideas. While not all of these picks will be winners, our research shows that these picks historically outperformed the market by double digits annually.
ContraFect Corp (NASDAQ:CFRX) was in 18 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic was previously 13. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. CFRX investors should be aware of an increase in support from the world’s most elite money managers lately. There were 10 hedge funds in our database with CFRX holdings at the end of December. Our calculations also showed that CFRX isn’t among the 30 most popular stocks among hedge funds (click for Q1 rankings).